128 related articles for article (PubMed ID: 8582760)
21. Some aspects of the neuropharmacology of phenylurea.
Zirvi KA; Fakouhi T
Arzneimittelforschung; 1977; 27(6):1194-8. PubMed ID: 578440
[TBL] [Abstract][Full Text] [Related]
22. Psychopharmacological studies on Tragia involucrata root extract.
Dhara AK; Pal S; Nag Chaudhuri AK
Phytother Res; 2002 Jun; 16(4):326-30. PubMed ID: 12112287
[TBL] [Abstract][Full Text] [Related]
23. [Substances with central nervous system activity. Derivatives of octahydro-1,4-dihydroxypyrrolo(1,2-a)pyrazine-6-carboxylic acids].
Occelli E; Mariani L; Fontanella L; Corsico N
Farmaco Sci; 1984 Aug; 39(8):718-38. PubMed ID: 6541160
[TBL] [Abstract][Full Text] [Related]
24. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
[TBL] [Abstract][Full Text] [Related]
25. The effects of aqueous extracts of Desmodium gangeticum DC. (Leguminosae) on the central nervous system.
Jabbar S; Khan MT; Choudhuri MS
Pharmazie; 2001 Jun; 56(6):506-8. PubMed ID: 11446174
[TBL] [Abstract][Full Text] [Related]
26. Ethanol blocks nicotine-induced seizures in mice: comparison with midazolam and baclofen.
Korkosz A; Zatorski P; Taracha E; Plaznik A; Kostowski W; Bienkowski P
Alcohol; 2006 Nov; 40(3):151-7. PubMed ID: 17418694
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic properties of the dilactone of bis-(beta-hydroxypropyl)-malonic acid.
Pelczarska A; Prastowski W
Arch Immunol Ther Exp (Warsz); 1967; 15(6):912-9. PubMed ID: 5586112
[No Abstract] [Full Text] [Related]
28. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
[TBL] [Abstract][Full Text] [Related]
29. Central activity of new xanthone derivatives with chiral center in some pharmacological tests in mice.
Jastrzebska-Wiesek M; Librowski T; Czarnecki R; Marona H; Nowak G
Pol J Pharmacol; 2003; 55(3):461-5. PubMed ID: 14506327
[TBL] [Abstract][Full Text] [Related]
30. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):349-54. PubMed ID: 10091720
[TBL] [Abstract][Full Text] [Related]
31. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
Mares P; Mikulecká A
Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655
[TBL] [Abstract][Full Text] [Related]
32. [Possibilities of detecting and differentiating central nervous effects of drugs in animal experiments with special consideration of behavioral-pharmacologic methods].
Hoffmeister F; Wuttke W
Arzneimittelforschung; 1975 Jul; 25(7a):1162-78. PubMed ID: 241358
[TBL] [Abstract][Full Text] [Related]
33. Anticonvulsant activities of nutmeg oil of Myristica fragrans.
Wahab A; Ul Haq R; Ahmed A; Khan RA; Raza M
Phytother Res; 2009 Feb; 23(2):153-8. PubMed ID: 19067329
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system activity of yangambin from Ocotea duckei Vattimo (Lauraceae) in mice.
de Sousa FC; Pereira BA; Lima VT; Lacerda CD; Melo CT; Barbosa-Filho JM; Vasconcelos SM; Viana GS
Phytother Res; 2005 Apr; 19(4):282-6. PubMed ID: 16041767
[TBL] [Abstract][Full Text] [Related]
35. [Neurophoarmacologic profile of an aminotetraline derivative].
Raĭnova L; Micheva M; Kharalambieva M; Staneva-Stoĭcheva D
Eksp Med Morfol; 1977; 16(4):211-6. PubMed ID: 590178
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of certain novel derivatives of 1H-pyrrolo[1,2-c][1,3]thiazine.
Jagodziński TS; Wesołowska A; Jagodzińska E; Rump S
Acta Pol Pharm; 2003; 60(1):67-73. PubMed ID: 12848370
[TBL] [Abstract][Full Text] [Related]
37. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice.
Umathe SN; Bhutada PS; Raut VS; Jain NS; Mundhada YR
Behav Pharmacol; 2009 Feb; 20(1):78-83. PubMed ID: 19106764
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system and other effects.
Young A
Adv Pharmacol; 2005; 52():281-8. PubMed ID: 16492554
[TBL] [Abstract][Full Text] [Related]
39. [Neurotoxicity in sodium azide poisoning].
Fujimura T; Kobayashi H; Suzuki T; Sato I; Hara S
Chudoku Kenkyu; 2002 Jul; 15(3):281-8. PubMed ID: 12415870
[TBL] [Abstract][Full Text] [Related]
40. Preclinical evaluation of PNU-151774E as a novel anticonvulsant.
Fariello RG; McArthur RA; Bonsignori A; Cervini MA; Maj R; Marrari P; Pevarello P; Wolf HH; Woodhead JW; White HS; Varasi M; Salvati P; Post C
J Pharmacol Exp Ther; 1998 May; 285(2):397-403. PubMed ID: 9580576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
